Florida Hospital Thoracic Cancer Program »

Lung Cancer Clinic

Each year more than 200,000 people are diagnosed with lung cancer. However, despite the serious nature of lung cancer, the prognosis for beating it is much better than it was even five years ago, thanks to early detection efforts and new treatment strategies.

Esophageal Cancer Clinic

Esophageal cancer accounts for more than 16,000 new cases each year. Thanks to improved treatments and early intervention, the survival rates for esophageal cancer have improved greatly since the 1960s when only a small percentage of people with the disease survived more than five years.

Mesothelioma Clinic

Most mesotheliomas begin in the chest cavity. Though fairly rare, there are still about 2,000 to 3,000 new cases each year, primarily in men over 65. Early detection and intervention by doctors at the Florida Hospital Cancer Institute's thoracic program is essential in treating the disease.

Lung Nodule Clinic

The presence of lung nodules does not automatically signal that you have cancer. Benign nodules can actually be quite common. To ensure that the nodules aren't cancerous, doctors at FHCI will monitor changes in size, shape or appearance through regular tests.

Uncommon Malignancies Clinic

Rare forms of cancer include carcinoid tumors, mediastinal tumors and thymoma. Each of these presents unique challenges that doctors at the Florida Hospital Cancer Institute address with a broad range of traditional and leading edge treatment strategies.

Who We Are

Sigfredo Aldarondo, MD

Learn more about the role of the pulmonologist in the treatment of thoracic cancer.

Click Here

Joseph Boyer, MD

Learn more about the role of the thoracic surgeon in the treatment of thoracic cancer.

Click Here

Brenda Rzeszutko, MSN, ARNP-BC

Learn more about the role of the care coordinator.

Click Here

Care Coordinators

Map and Directions

Meet Our Physicians

Printer-friendly versionPrinter-friendly versionSend to friendSend to friend

Some of the most renowned cancer specialists in the world call Central Florida their home. All are highly qualified, board-certified physicians who are leaders in their respective fields of expertise. The team includes principal investigators of more than 100 clinical trials and research studies that are evaluating new cancer prevention and treatment options that could lead to new therapies, or perhaps one day, a cure for thoracic cancer.

Medical Leadership

Tarek M Mekhail, MD

Joseph H Boyer Jr, MD

Physicians by Specialities

Hematology and Oncology

Carlos Alemany, MD

Stefani L Capone, MD

Raul C Castillo, MD

Ricardo H Crisostomo, MD

Philip H Dunn, MD

Sarah K George, MD

William B Grow, MD

Linda F Lukman, MD

Tarek M Mekhail, MD

David C Molthrop, MD

Robert B Reynolds, MD

David Robinson, MD

Sonalee K Shroff, MD

Ahmed Zakari, MD

Lee M Zehngebot, MD

Thoracic & Cardiovascular Surgery

Kevin D Accola, MD

Joseph H Boyer Jr, MD

Alessandro Ferrero, MD

Nayer N Khouzam, MD

George J Palmer, MD

Jorge E Suarez- Cavalier, MD

Radiation Oncology

Rahul R Chopra, MD

David A Diamond, MD

Kelly LaFave, MD

Eric L Saunders, MD

Robert J Sollaccio, MD

Michael D Sombeck, MD

Pulmonary Diseases

Mahmood Ali, MD

Fortune O Alabi, MD

Sigfredo Aldarondo, MD

Francisco J Calimano, MD

Kevin D DeBoer, DO

Faisal A Fakih, MD

Ruel Garcia, MD

Eugene Go, MD

Yitzhak Dani Haim, MD

Jorge L Hernandez, MD

Daniel T Layish, MD

Ahmed Masood, MD

Syed I Mobin, MD

Andres Pelaez, MD

Tabarak Qureshi, MD

Francisco J Remy, MD

Fred C Umeh, MD

Steve D Vu, MD

 

Gastroenterology

Barry R Katz, MD

David H Lebioda, MD

Andria M Mushahwar, MD

Raaj K Popli, MD

Sanjay K Reddy, MD

Harry H Shephard, MD

Richard J Straker II, MD

Philip N Styne, MD